$
RXMD
News: Progressive Care Enters into Letter of Intent to Acquire Telehealth Service Provider MyApps Corp.
MIAMI, FL, Sept. 08, 2020 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- Progressive Care Inc. (OTCQB: RXMD ) (“Progressive Care” or the “Company”), a personalized healthcare services and technology company, is excited to announce that on September 1, 2020, the Company entered into a Letter of Intent (the “LOI”) to acquire one hundred percent (100%) of MyApps Corp. (“MyApps”) (myapps.solutions), a leading developer of healthcare software, which includes the emerging telehealth service app CallingDr™ (callingdr.com). In addition, Progressive Care will be immediately engaging MyApps to accelerate development of software platforms for ClearMetRX, Progressive Care’s wholly-owned data management subsidiary, and its divisions. MyApps is a commercial-stage software developer on pace to record over $1 million in revenues in 2020.
Pursuant to the LOI, purchase price for the acquisition will be approximately $10,200,000, $7,500,000 of which will be paid in the form of Progressive Care common stock, at a price per share to be determined in accordance with the definitive agreement, and the remaining $2,700,000 of which will be paid in two annual installments, subject to the achievement of certain performance criteria.
Following execution of the LOI, the parties began negotiating definitive acquisition agreement, with the expectation of executing and delivering the definitive acquisition agreement on or before October 31, 2020. The completion of the acquisition is conditioned upon completion of due diligence procedures and the negotiation and execution of employment agreements and other ancillary documents.
Upon completion of the closing of the acquisition, Progressive Care will begin to provide health IT, HIPAA-compliant software development, HL7 integrations, and virtual healthcare services on a business-to-business (B2B) basis to hundreds of clients spanning the global healthcare distribution landscape, delivering services directly to consumers and through channel partners.
As noted above, MyApps fully owns the popular telemedicine and telehealth platform, CallingDr™, which is a complete virtual platform providing multiple levels of service with a suite of products, including the capability to allow patients to take ownership of their own health records and provide access to health information through the related app and patient portal. MyApps software is currently used in hundreds of medical practices in multiple states, including gastrointestinal, internal medicine, psychiatry, pulmonology, cardiology as well as remote clinics and in-patient settings. Customers include single-physician clinics, multi-physician clinics, emergency room centers, nursing homes, and home health setups.
• CallingDr™ was ranked in the top ten list of patient engagement solution providers by Healthcare Tech Magazine in 2019.
• CallingDr™ has already been integrated to work seamlessly with Thinklabs Stethoscopes.
• CallingDr™ has been integrated into PointClickCare, the leading cloud-based Electronic Health Record (EHR) software designed specifically for the long-term care providers system.
• Technology Innovators, a leading tech-based digital publication, listed CallingDr™ as one of the top 20 Innovators in Telemedicine for 2020.
The CallingDr™ white-label software platform delivers features and functionality optimized to provide long-distance medical telehealth care, offering doctors the tools to manage clients through patient-doctor video, audio, and SMS HIPAA-compliant consulting and remote patient monitoring.
The CallingDr™ platform makes it simple for patients to interact with and consult physicians from the comfort of home, outside of conventional clinical settings, with no need to travel long distances to see a physician. This increases access to health care, improves quality of care, and decreases healthcare delivery costs by allowing for the secure transfer of data from patients to health professionals in real time.
The platform is unique – designed for ambulatory as well as in-patient settings, including post-acute and long-term care, with priority emphasis on easy adoption of telemedicine into existing practices. The mobile health platform integrates with smart devices and securely collects and transmits patient data to a physician for remote monitoring.
MyApps has also developed several other platforms that provide improvements in charging, capturing, and billing healthcare services for hospitals, as well as enabling patients better access to healthcare options in their communities by finding available doctor and insurance information in real-time.
“Following the completion of the acquisition, we plan to market the software to the physicians who are currently our clients, and then to the entire community of physicians, medical practices, therapists, remote rehab centers, and nursing homes across the United States,” commented Alan J. Weisberg, interim CEO and Chairman of the Board at Progressive Care. “Following the sharp and significant deregulation of the Telehealth system we have seen over recent months, the door to a very different – and far more efficient – overarching healthcare paradigm has been thrown wide open. And MyApps has already built something with revolutionary potential, making this strategic move a grand slam home run for Progressive Care given our stated objective to become a global leader in the delivery and integration of Telehealth and Telemedicine services.”
MyApps Founder and CEO, Adnan Malik, added, “We look forward to joining the Progressive Care team, which will provide MyApps with a spectacular backing and platform to continue to drive value as an organization bent on changing the healthcare system from the ground up. Telehealth has been a revolution in the making for a decade or more. But the COVID-19 crisis has finally kicked down the doors and taken the system past the point of no return. With unnecessary regulatory barriers out of the way, the stage is set for an aggressive realignment in favor of telehealth solution providers.”
For more information about Progressive Care, please visit the company’s website.
Connect and stay in touch with us on social media:
Progressive Care Inc.
https://www.facebook.com/ProgressiveCareUS/
https://twitter.com/ProgressCareUS
PharmCo, LLC
https://www.facebook.com/pharmcorx/
https://twitter.com/PharmCoRx
About Progressive Care Inc.
Progressive Care Inc. (OTCQB: RXMD), through its subsidiaries, is a Florida health services organization and provider of prescription pharmaceuticals, compounded medications, provider of tele-pharmacy services, the sale of anti-retroviral medications, medication therapy management (MTM), the supply of prescription medications to long-term care facilities, and health practice risk management.
Cautionary Statement Regarding Forward-Looking Statements
Statements contained herein that are not based upon current or historical fact are forward-looking in nature and constitute forward-looking statements within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934. Such forward-looking statements reflect the Company’s expectations about its future operating results, performance, and opportunities that involve substantial risks and uncertainties. These statements include but are not limited to statements regarding the Company’s planned acquisition of MyApps Corp., the negotiation and execution of a share exchange agreement and completion of due diligence and other closing conditions, the Company’s plans for provision of services and integration of MyApps Corp. operations following completion of the acquisition and the benefits of MyApps Corp.’s products and services. When used herein, the words “anticipate,” “believe,” “estimate,” “upcoming,” “plan,” “target,” “intend” and “expect” and similar expressions, as they relate to Progressive Care Inc., its subsidiaries, or its management, are intended to identify such forward-looking statements. These forward-looking statements are based on information currently available to the Company and are subject to a number of risks, uncertainties, and other factors that could cause the Company’s actual results, performance, prospects, and opportunities to differ materially from those expressed in, or implied by, these forward-looking statements, including, without limitation, the risk that the Company may not be able to successfully negotiate or execute a share purchase agreement for, or close, the acquisition of MyApps Corp. and, if we are able to successfully acquire MyApps Corp., the Company may not be successful in integrating MyApps Corp.’s operations and may not be able to capture financial benefits from acquisition.
Investor Relations Contact:
Armen Karapetyan, Progressive Care
Senior Advisor Business Development
Armen@progressivecareus.com
www.progressivecareus.com
www.pharmcorx.com
Public Relations Contact:
Carlos Rangel
carlosr@pharmcorx.com
MIAMI, FL, Sept. 08, 2020 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- Progressive Care Inc. (OTCQB: RXMD ) (“Progressive Care” or the “Company”), a personalized healthcare services and technology company, is excited to announce that on September 1, 2020, the Company entered into a Letter of Intent (the “LOI”) to acquire one hundred percent (100%) of MyApps Corp. (“MyApps”) (myapps.solutions), a leading developer of healthcare software, which includes the emerging telehealth service app CallingDr™ (callingdr.com). In addition, Progressive Care will be immediately engaging MyApps to accelerate development of software platforms for ClearMetRX, Progressive Care’s wholly-owned data management subsidiary, and its divisions. MyApps is a commercial-stage software developer on pace to record over $1 million in revenues in 2020.
Pursuant to the LOI, purchase price for the acquisition will be approximately $10,200,000, $7,500,000 of which will be paid in the form of Progressive Care common stock, at a price per share to be determined in accordance with the definitive agreement, and the remaining $2,700,000 of which will be paid in two annual installments, subject to the achievement of certain performance criteria.
Following execution of the LOI, the parties began negotiating definitive acquisition agreement, with the expectation of executing and delivering the definitive acquisition agreement on or before October 31, 2020. The completion of the acquisition is conditioned upon completion of due diligence procedures and the negotiation and execution of employment agreements and other ancillary documents.
Upon completion of the closing of the acquisition, Progressive Care will begin to provide health IT, HIPAA-compliant software development, HL7 integrations, and virtual healthcare services on a business-to-business (B2B) basis to hundreds of clients spanning the global healthcare distribution landscape, delivering services directly to consumers and through channel partners.
As noted above, MyApps fully owns the popular telemedicine and telehealth platform, CallingDr™, which is a complete virtual platform providing multiple levels of service with a suite of products, including the capability to allow patients to take ownership of their own health records and provide access to health information through the related app and patient portal. MyApps software is currently used in hundreds of medical practices in multiple states, including gastrointestinal, internal medicine, psychiatry, pulmonology, cardiology as well as remote clinics and in-patient settings. Customers include single-physician clinics, multi-physician clinics, emergency room centers, nursing homes, and home health setups.
• CallingDr™ was ranked in the top ten list of patient engagement solution providers by Healthcare Tech Magazine in 2019.
• CallingDr™ has already been integrated to work seamlessly with Thinklabs Stethoscopes.
• CallingDr™ has been integrated into PointClickCare, the leading cloud-based Electronic Health Record (EHR) software designed specifically for the long-term care providers system.
• Technology Innovators, a leading tech-based digital publication, listed CallingDr™ as one of the top 20 Innovators in Telemedicine for 2020.
The CallingDr™ white-label software platform delivers features and functionality optimized to provide long-distance medical telehealth care, offering doctors the tools to manage clients through patient-doctor video, audio, and SMS HIPAA-compliant consulting and remote patient monitoring.
The CallingDr™ platform makes it simple for patients to interact with and consult physicians from the comfort of home, outside of conventional clinical settings, with no need to travel long distances to see a physician. This increases access to health care, improves quality of care, and decreases healthcare delivery costs by allowing for the secure transfer of data from patients to health professionals in real time.
The platform is unique – designed for ambulatory as well as in-patient settings, including post-acute and long-term care, with priority emphasis on easy adoption of telemedicine into existing practices. The mobile health platform integrates with smart devices and securely collects and transmits patient data to a physician for remote monitoring.
MyApps has also developed several other platforms that provide improvements in charging, capturing, and billing healthcare services for hospitals, as well as enabling patients better access to healthcare options in their communities by finding available doctor and insurance information in real-time.
“Following the completion of the acquisition, we plan to market the software to the physicians who are currently our clients, and then to the entire community of physicians, medical practices, therapists, remote rehab centers, and nursing homes across the United States,” commented Alan J. Weisberg, interim CEO and Chairman of the Board at Progressive Care. “Following the sharp and significant deregulation of the Telehealth system we have seen over recent months, the door to a very different – and far more efficient – overarching healthcare paradigm has been thrown wide open. And MyApps has already built something with revolutionary potential, making this strategic move a grand slam home run for Progressive Care given our stated objective to become a global leader in the delivery and integration of Telehealth and Telemedicine services.”
MyApps Founder and CEO, Adnan Malik, added, “We look forward to joining the Progressive Care team, which will provide MyApps with a spectacular backing and platform to continue to drive value as an organization bent on changing the healthcare system from the ground up. Telehealth has been a revolution in the making for a decade or more. But the COVID-19 crisis has finally kicked down the doors and taken the system past the point of no return. With unnecessary regulatory barriers out of the way, the stage is set for an aggressive realignment in favor of telehealth solution providers.”
For more information about Progressive Care, please visit the company’s website.
Connect and stay in touch with us on social media:
Progressive Care Inc.
https://www.facebook.com/ProgressiveCareUS/
https://twitter.com/ProgressCareUS
PharmCo, LLC
https://www.facebook.com/pharmcorx/
https://twitter.com/PharmCoRx
About Progressive Care Inc.
Progressive Care Inc. (OTCQB: RXMD), through its subsidiaries, is a Florida health services organization and provider of prescription pharmaceuticals, compounded medications, provider of tele-pharmacy services, the sale of anti-retroviral medications, medication therapy management (MTM), the supply of prescription medications to long-term care facilities, and health practice risk management.
Cautionary Statement Regarding Forward-Looking Statements
Statements contained herein that are not based upon current or historical fact are forward-looking in nature and constitute forward-looking statements within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934. Such forward-looking statements reflect the Company’s expectations about its future operating results, performance, and opportunities that involve substantial risks and uncertainties. These statements include but are not limited to statements regarding the Company’s planned acquisition of MyApps Corp., the negotiation and execution of a share exchange agreement and completion of due diligence and other closing conditions, the Company’s plans for provision of services and integration of MyApps Corp. operations following completion of the acquisition and the benefits of MyApps Corp.’s products and services. When used herein, the words “anticipate,” “believe,” “estimate,” “upcoming,” “plan,” “target,” “intend” and “expect” and similar expressions, as they relate to Progressive Care Inc., its subsidiaries, or its management, are intended to identify such forward-looking statements. These forward-looking statements are based on information currently available to the Company and are subject to a number of risks, uncertainties, and other factors that could cause the Company’s actual results, performance, prospects, and opportunities to differ materially from those expressed in, or implied by, these forward-looking statements, including, without limitation, the risk that the Company may not be able to successfully negotiate or execute a share purchase agreement for, or close, the acquisition of MyApps Corp. and, if we are able to successfully acquire MyApps Corp., the Company may not be successful in integrating MyApps Corp.’s operations and may not be able to capture financial benefits from acquisition.
Investor Relations Contact:
Armen Karapetyan, Progressive Care
Senior Advisor Business Development
Armen@progressivecareus.com
www.progressivecareus.com
www.pharmcorx.com
Public Relations Contact:
Carlos Rangel
carlosr@pharmcorx.com
What I post is my opinion. Do your own DD. Make your own investment decision. Links, images, & retweets are not endorsements.
1️⃣I do not provide personal investment advice and I am not a qualified licensed investment advisor. I am an amateur investor.
2️⃣All information found here, including any ideas, opinions, views, predictions, forecasts, commentaries, suggestions, or stock picks, expressed or implied herein, are for informational, entertainment or educational purposes only and should not be construed as personal investment advice. While the information provided is believed to be accurate, it may include errors or inaccuracies.
3️⃣I will not and cannot be held liable for any actions you take as a result of anything you read here.
4️⃣Conduct your own due diligence, or consult a licensed financial advisor or broker before making any and all investment decisions. Any investments, trades, speculations, or decisions made on the basis of any information found on this site, expressed or implied herein, are committed at your own risk, financial or otherwise.
4️⃣Not Financial Advice. What I post is my opinion.
Also Paid for Advertising/IR/PR on Emerging Companies
Full Disclaimer: https://corporateads.com/disclaimer/
1️⃣I do not provide personal investment advice and I am not a qualified licensed investment advisor. I am an amateur investor.
2️⃣All information found here, including any ideas, opinions, views, predictions, forecasts, commentaries, suggestions, or stock picks, expressed or implied herein, are for informational, entertainment or educational purposes only and should not be construed as personal investment advice. While the information provided is believed to be accurate, it may include errors or inaccuracies.
3️⃣I will not and cannot be held liable for any actions you take as a result of anything you read here.
4️⃣Conduct your own due diligence, or consult a licensed financial advisor or broker before making any and all investment decisions. Any investments, trades, speculations, or decisions made on the basis of any information found on this site, expressed or implied herein, are committed at your own risk, financial or otherwise.
4️⃣Not Financial Advice. What I post is my opinion.
Also Paid for Advertising/IR/PR on Emerging Companies
Full Disclaimer: https://corporateads.com/disclaimer/
